Company news
Changchun BCHT Biotechnology Co. news in 2024
Changchun BCHT Biotechnology Co.'s news releases, calls and decks from 2024, newest first.
Announcement on the Approval of Voluntary Disclosure of Clinical Trial Application for Freeze-dried Haemophilus Influenzae Type b Conjugate Vaccine
December 25, 2024
Announcement on Voluntary Disclosure of Approval for Clinical Trial Application of Type II Herpes Simplex Virus mRNA Vaccine
December 20, 2024
Announcement on Completing Term Change and Election of the Board of Directors and the Board of Supervisors and Appointing Senior Management Members and Securities Affairs Representative
December 10, 2024
Announcement on Electing Employee Representative Supervisor of the 6th Board of Supervisors
November 22, 2024
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares to 5%
November 6, 2024
Report for Q3 2024
October 25, 2024
Announcement on Convening Performance Briefing for Q3 2024
October 18, 2024
Announcement on the Judicial Freezing of Partial Shares Held by Shareholders with over 5% Shareholding
October 8, 2024
Announcement on Shareholding Reduction Plan through Call Auction by Shareholders Holding Over 5% of Shares
September 13, 2024
Announcement on Returning Raised Funds Previously Used to Temporarily Supplement Current Capital and Using Some Idle Raised Funds to Temporarily Supplement Current Capital
August 15, 2024
Announcement on Convening Semi-annual Performance Briefing 2024
August 8, 2024
Announcement on Adjusting the Grant Price of Restricted Stock in the 2022 Restricted Stock Incentive Plan
July 19, 2024
Announcement on Voluntary Commitment by Controlling Shareholder, Shareholder with Over 5% Shares, Director, and General Manager Not to Reduce Shareholding in Next Six Months
June 24, 2024
Announcement on Circulation of Some Restricted Shares in Initial Public Offering
June 14, 2024
Announcement on Attending Online Collective Performance Meeting
May 20, 2024
Announcement on Implementation of Dividend Distribution for 2023
May 16, 2024
Announcement on Vesting Result in 1st Vesting Period of Initially Granted Part under Restricted Shares Incentive Plan of 2022 and Shares Listing
April 25, 2024